University of Glasgow

University of Glasgow funded projects

 

Code	Title	PI	Funding Amount	Partners	Lay Summary	Project Report
COV/GLA/20/02	ASTERIX: adaptive salvage treatment based on endotype-directed anti-virals and immunomodulation – an NHS framework to enable research and clinical trials	Prof Kevin Blyth	£17,000	CRUK Glasgow CTU NHS GGC	COV/GLA/20/02 Lay Summary
COV/GLA/20/03	Glasgow Early Treatment Arm Favipiravir (GETAFIX): a randomised controlled study favipiravir as an early treatment arm of ASTERIX in Covid-19 Hospitalised patients	Dr Janet Scott	£156,510	NHS GGC University of Strathclyde	COV/GLA/20/03 Lay Summary
COV/GLA/20/04	Hypertension, inhibitors of the renin angiotensin system and Covid-19	Dr Rhain Touyz	£79,846		COV/GLA/20/04 Lay Summary	COV/GLA/20/04 final report
COV/GLA/20/05	Cardiac Imaging in SARS Coronavirus disease-19 (CISCO-19)	Prof Colin Berry	£47,940	NHS GGC	COV/GLA/20/05 Lay Summary	COV/GLA/20/05 final report
COV/GLA/20/06	CARP: Covid-19 Advanced respiratory physiological platform	Dr Chris Carlin	£123,850	NHS GGC Altair Medical Storm ID	COV/GLA/20/06 Lay Summary	COV/GLA/20/06 final report
COV/GLA/20/07	Viral and Immunological correlates of clinical severity and response to anti-viral therapy for Covid-19	Prof Carl Goodyear	£319,473	NHS GGC	COV/GLA/20/07 Lay Summary
COV/GLA/20/08	Markers of disease: identifying bacterial secondary infections in Covid-19 patients	Prof Andrew Roe	£56,970	NHS GGC	COV/GLA/20/08 Lay Summary
COV/GLA/20/11	Understanding longer term impacts of social distancing and behavioural interventions introduced to prevent the spread of infection in the population	Dr Katie Robb	£37,000		COV/GLA/20/11 Lay Summary	COV/GLA/20/11 final report
COV/GLA/20/12	Social and health impacts of Covid-19 suppression in vulnerable groups	Prof Sarah Armstrong Dr Lucy Pickering	£186,869	7 Partner organisations who support the population groups addressed	COV/GLA/20/12 Lay Summary	COV/GLA/20/12 final report